Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03442088
Recruitment Status : Recruiting
First Posted : February 22, 2018
Last Update Posted : September 27, 2019
Sponsor:
Information provided by (Responsible Party):
Neil Korman, University Hospitals Cleveland Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : June 30, 2020
Publications: